These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 9705241

  • 1. Age as a risk factor for myocardial infarction in Leiden mutation carriers.
    Baranovskaya S, Kudinov S, Fomicheva E, Vasina V, Solovieva D, Khavinson V, Schwartz E.
    Mol Genet Metab; 1998 Jun; 64(2):155-7. PubMed ID: 9705241
    [Abstract] [Full Text] [Related]

  • 2. [Effects of factor V Leiden mutations on prognosis in patients with acute myocardial infarction].
    Baykan M, Celik S, Uçar F, Kaplan S, Ovali E, Erdöl C.
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):242-5; AXIV. PubMed ID: 12101832
    [Abstract] [Full Text] [Related]

  • 3. Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
    French JK, Van de Water NS, Sutton TM, Lund M, Gao W, McDowell J, Liu-Stratton Y, Pohorence J, Szymanski D, Goldschmidt-Clermont P, White HD, Browett PJ, Cooke G.
    Am Heart J; 2003 Jan; 145(1):118-24. PubMed ID: 12514663
    [Abstract] [Full Text] [Related]

  • 4. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S, O'Donnell KA, O'Neill C, Mayne PD, Thornton P, Naughten E.
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [Abstract] [Full Text] [Related]

  • 5. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V, Marino R, Scaraggi FA, Di Bari L, Giannoccaro F, Petronelli M, Ranieri P, Tannoia N, Schiraldi O.
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [Abstract] [Full Text] [Related]

  • 6. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
    Linnemann B, Schindewolf M, Zgouras D, Erbe M, Jarosch-Preusche M, Lindhoff-Last E.
    Thromb Res; 2008 Oct; 121(6):743-50. PubMed ID: 17804043
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
    Middendorf K, Göhring P, Huehns TY, Seidel D, Steinbeck G, Nikol S.
    Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
    [Abstract] [Full Text] [Related]

  • 8. Haemostatic gene polymorphisms in young indian asian subjects with acute myocardial infarction.
    Ranjith N, Pegoraro RJ, Rom L.
    Med Sci Monit; 2003 Oct; 9(10):CR417-21. PubMed ID: 14523329
    [Abstract] [Full Text] [Related]

  • 9. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.
    Clin Ter; 2003 Oct; 154(5):299-303. PubMed ID: 14994919
    [Abstract] [Full Text] [Related]

  • 10. Factor V Leiden mutation in patients with Behçet's disease.
    Oner AF, Gürgey A, Gürler A, Mesci L.
    J Rheumatol; 1998 Mar; 25(3):496-8. PubMed ID: 9517770
    [Abstract] [Full Text] [Related]

  • 11. [Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes].
    Alvarez A, Barroso A, Robledo M, Arranz E, Outeiriño J, Benítez J.
    Sangre (Barc); 1999 Feb; 44(1):7-12. PubMed ID: 10323090
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
    Ioannou HV, Mitsis M, Eleftheriou A, Matsagas M, Nousias V, Rigopoulos C, Vartholomatos G, Kappas AM.
    Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
    [Abstract] [Full Text] [Related]

  • 13. Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation.
    Brown K, Luddington R, Taylor SA, Lillicrap DP, Baglin TP.
    Br J Haematol; 1999 Apr; 105(1):95-7. PubMed ID: 10233369
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
    Cushman M, Rosendaal FR, Psaty BM, Cook EF, Valliere J, Kuller LH, Tracy RP.
    Thromb Haemost; 1998 May; 79(5):912-5. PubMed ID: 9609219
    [Abstract] [Full Text] [Related]

  • 15. [Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke].
    Pongrácz E, Tordai A, Csornai M, Béla Z, Nagy Z.
    Ideggyogy Sz; 2003 May 20; 56(5-6):157-64. PubMed ID: 12861956
    [Abstract] [Full Text] [Related]

  • 16. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
    Strandberg K, Svensson PJ, Ohlin AK.
    Thromb Res; 2007 May 20; 121(2):145-51. PubMed ID: 17499343
    [Abstract] [Full Text] [Related]

  • 17. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 20; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 18. Factor V (Arg 506-->Gln) mutation in young survivors of myocardial infarction.
    Ardissino D, Peyvandi F, Merlini PA, Colombi E, Mannucci PM.
    Thromb Haemost; 1996 May 20; 75(5):701-2. PubMed ID: 8725707
    [Abstract] [Full Text] [Related]

  • 19. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G.
    Blood Coagul Fibrinolysis; 2003 Jan 20; 14(1):49-56. PubMed ID: 12544728
    [Abstract] [Full Text] [Related]

  • 20. The HR2 haplotype of factor V is not associated with the risk of myocardial infarction.
    Doggen CJ, de Visser MC, Vos HL, Bertina RM, Cats VM, Rosendaal FR.
    Thromb Haemost; 2000 Nov 20; 84(5):815-8. PubMed ID: 11127862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.